Prognosis Factors and Outcomes of Neuro-ophthalmologic Sarcoidosis.
Mathilde LeclercqDaniel LevyCatherine Chapelon-AbricAnne Claire DesboisFanny DomontElisabeth MaillartNatalia ShorCatherine VignalAntoine GuéguenBahram BodaghiPatrice CacoubValerie TouitouDavid SaadounPublished in: Ocular immunology and inflammation (2020)
Background: Neuro-ophthalmologic manifestations are uncommon in sarcoidosis. We aim to assess the prognostic factors and outcome of neuro-ophthalmic sarcoidosis.Methods: We conducted a multicenter retrospective study on patients with neuro-ophthalmic sarcoidosis. Response to therapy was based on visual acuity, visual field, and orbital MRI exam. Factors associated with remission and relapse were analyzed.Results: Thirty-five patients [median (IQR) age of 37 years (26.5-53), 63% of women] were included. The diagnosis of sarcoidosis was concomitant of neuro-ophthalmologic symptoms in 63% of cases. Optic neuritis was the most common manifestation. All patients received corticosteroids and 34% had immunosuppressants. At 6 months, 61% improved, 30% were stable, and 9% worsened. Twenty percent of patients had severe visual deficiency at the end of follow-up. Nonresponders patients had significantly worse visual acuity at baseline (p = 0.01). Relapses were less frequent in patients with retro-bulbar optic neuropathy (p = 0.03).Conclusion: Prognosis of neuro-ophthalmic sarcoidosis is poor.
Keyphrases
- prognostic factors
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- clinical trial
- magnetic resonance imaging
- pregnant women
- type diabetes
- metabolic syndrome
- patient reported outcomes
- systemic lupus erythematosus
- magnetic resonance
- physical activity
- computed tomography
- skeletal muscle
- polycystic ovary syndrome
- cross sectional
- drug induced
- patient reported
- free survival